Key result
Eight candidate genes emerge as highly sensitive diagnostic markers for HF with AUCs >0.8.
Why the study?
Heart failure adversely affects quality of life and understanding its biology is needed to identify candidate markers for effective diagnosis and treatment.
Population
Heart failure and non-failing samples from GSE116250 and GSE141910 datasets
Comparison
Heart failure samples vs non-failing samples
Design
Observational gene expression profiling with LASSO and immune cell infiltration analysis
Authors
Loading...
May inform HF biomarker discovery; leaves open prospective clinical validation before diagnostic or therapeutic use.
Observational (n=440)
Bioinformatics analysis identified eight candidate genes and immune cell infiltration patterns that may serve as potential diagnostic markers and therapeutic targets for heart failure.
Wang et al. (2022) conducted an observational in Heart failure (n=440). Heart failure vs. Non-failing controls was evaluated on Diagnostic performance of candidate genes for heart failure. Eight candidate genes (PHLDA1, C1QTNF2, SPC24, FNDC1, FREM1, SLC16A9, PLA2G2A, and S1PR3) were identified as highly sensitive diagnostic markers for heart failure, with AUC values greater than 0.8.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: